Home » Topics » BioWorld Science

BioWorld Science
RSS

Ningbo Combireg Pharmaceutical Technology presents deuterated anticancer compounds

June 9, 2022

ATP spreads inflammation by activating neural pathway and enhancing IL-6 amplifier

June 9, 2022

French researchers patent gold complexes and their use as antioxidants

June 9, 2022

CURACLE and collaborators patent carbazole derivative angiogenesis inhibitors

June 9, 2022

Humanwell Healthcare discloses LPAR1 antagonists

June 9, 2022

WNT plays dual role in melanoma spread to lung

June 8, 2022

Coya raises financing to advance Treg-derived exosome therapeutics into clinic

June 8, 2022

Kiromic enters SRA with MD Anderson to support IND filings for gamma delta T-cell product candidates

June 8, 2022

Targeting NLRP3 inflammasome pathway prevents C. septicum-induced lethality

June 8, 2022

Find Therapeutics and SATT Conectus sign licensing agreement for new approach to treat MS

June 8, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...